Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in Targeted Therapy for the Treatment of Cervical Cancer
Dean Watkins, Daniel J. Craig, Shahnaz D. Vellani, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 18, pp. 5992-5992
Open Access | Times Cited: 17

Showing 17 citing articles:

TPP-based conjugates: potential targeting ligands
Sanya Batheja, Shruti Gupta, Kiran Kumar Tejavath, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 6, pp. 103983-103983
Closed Access | Times Cited: 7
Emerging biomarkers and molecular targets for precision medicine in cervical cancer
Pankaj Garg, Madhu Krishna, Ayalur Raghu Subbalakshmi, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 3, pp. 189106-189106
Closed Access | Times Cited: 6
Systematic Review on the Effectiveness and Outcomes of Nivolumab Treatment Schemes in Advanced and Metastatic Cervical Cancer
Ion Petre, Corina Vernic, Izabella Petre, et al.
Diseases (2024) Vol. 12, Iss. 4, pp. 77-77
Open Access | Times Cited: 4
Real-world data analysis of topotecan in combination with Bevacizumab or CycloPhosphamide in the FDA adverse event reporting system (FAERS) database
Huihui Chen, Guang‐lun Zhuang, Shihao Hong, et al.
Expert Opinion on Drug Safety (2025), pp. 1-12
Closed Access
The future of cervical cancer prevention: advances in research and technology
Praveen Kumar Chandra Sekar, Sheena Mariam Thomas, Ramakrishnan Veerabathiran
Exploration of Medicine (2024), pp. 384-400
Open Access | Times Cited: 3
Application of Probiotics in Cervical Cancer Infections to Enhance the Immune Response
Yatakona Supriya, Sathasivam Sivamalar, Nallusamy Duraisamy, et al.
Microbial Pathogenesis (2024) Vol. 193, pp. 106764-106764
Closed Access | Times Cited: 3
Immune cell infiltration and prognostic index in cervical cancer: insights from metabolism-related differential genes
Boyi Ma, Chenlu Ren, Yadong Yin, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Inhibition of ADAM17 increases the cytotoxic effect of cisplatin in cervical spheroids and organoids
D Holthaus, Christoph Rogmans, Ina Gursinski, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Advancing Immunotherapy in Pancreatic Cancer
Ahmad Hegazi, Lauren Elizabeth Rager, Dean Watkins, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11560-11560
Open Access | Times Cited: 2
The Role of Lymph Node Downstaging Following Neoadjuvant Treatment in a Group of Patients with Advanced Stage Cervical Cancer
Irinel-Gabriel Dicu-Andreescu, Marian-Augustin Marincaș, Anca A. Simionescu, et al.
Medicina (2024) Vol. 60, Iss. 6, pp. 871-871
Open Access | Times Cited: 1
Atezolizumab plus bevacizumab and chemotherapy versus bevacizumab plus chemotherapy for metastatic cervical cancer: a cost-effectiveness analysis
Hongfu Cai, Ling Fang, Jingwen Lin, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Long term clinical outcomes of cervical cancer patients who were recommended surgery but did not undergo it: A SEER database study
Zhaoming Zhang, Hongfu Zhao, Guanghui Cheng
European Journal of Surgical Oncology (2024) Vol. 50, Iss. 10, pp. 108572-108572
Closed Access | Times Cited: 1
Inhibition of ADAM17 increases cytotoxic effect of cisplatin in cervical spheroids and organoids
D Holthaus, Christoph Rogmans, Ina Gursinski, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
MCPIP1 Elicits a Therapeutic Effect on Cervical Cancer by Facilitating XIAP mRNA Decay via Its Endoribonuclease Activity
Junyun Luo, Ling He, Yanxia Guo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10285-10285
Open Access
Identification of Vesicle‐Mediated Transport‐Related Genes for Predicting Prognosis, Immunotherapy Response, and Drug Screening in Cervical Cancer
Shuai Lou, Hongqing Lv, Lin Zhang
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 11
Open Access
Interplay between reactive oxygen species and ERK activation in cervical cancer cells
Karen Andrea Larrauri-Rodríguez, Bertha Alicia León‐Chávez, Verónica Vallejo-Ruíz, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access
HPV Status and Staging in Oropharyngeal Carcinoma: A Review of Recent AJCC/UICC Revisions
Madhan Krishnan, Basappa Basappa, Shyamaladevi Babu, et al.
Oral Oncology Reports (2024), pp. 100694-100694
Open Access
Molecular mechanism of tumor microenvironment and recent approaches for the immunotherapy of pancreatic cancer
Ayesha Fazal Nawaz, Muhammad Arif
Asia-Pacific Journal of Oncology (2024)
Open Access
Page 1

Scroll to top